Jeffrey G. Stark, PhD
Jeffrey G. Stark, PhD
Worldwide Clinical Trials
8605 Cross Park Dr.
Austin,
TX
USA
78754
Papers:
3.40
Oral Bioavailability/Bioequivalence of a Novel Investigational Extended-Release Oral Disintegrating Tablet Formulation of Amphetamine for ADHD
3.41
Pharmacokinetic Study of a Novel Extended-Release Formulation of Amphetamine Oral Disintegrating Tablet in Children Ages 6-12 with ADHD